CARLSMED, INC. (CARL) Cash Flow Statement
CARLSMED, INC. (CARL) generated -$34.1M of operating cash flow over the twelve months to 2026-06-30, spent $1.5M on capital expenditure and had free cash flow of -$35.7M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
CARLCARLSMED, INC.Follow CARL — free
—
Price chart with a free account
- Market cap
- 396.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|
| Operating cash flow | -25.5 | -29.0 | -34.1 | |
| Capital expenditure | 0.2 | 1.4 | -1.5 | |
| Free cash flow | -25.6 | -30.3 | -35.7 | |
| Stock-based compensation | 0.3 | 1.9 | — |
USD millions · SEC XBRL
CARLSMED, INC. — questions
- What is CARLSMED, INC.'s operating cash flow?
- -$34.1M over the twelve months to 2026-06-30.
- How much does CARLSMED, INC. spend on capital expenditure?
- $1.5M over the twelve months to 2026-06-30.
- What is CARLSMED, INC.'s free cash flow?
- -$35.7M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from CARLSMED, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.